CSPC Pharmaceutical Group Limited
CSPCYOTCHealthcare● Active
$3.64
+$0.00(+0.00%)
Market Cap$10.5B
P/E Ratio—
52W High$5.83
52W Low$3.45
CSPC Pharmaceutical Group Limited (CSPCY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CSPCY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 27, 2026EPS Actual
$0.06
Revenue
$1.60B
Est. $7.58B · -78.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 27, 2026
After Market Close
▼ Miss Revenue
CSPCY reports quarterly as a OTC-listed Drug Manufacturers - General company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 27, 2026 | — | $0.06 | — | $1.60B | $7.58B | -78.8% |
| ◌ Q3 FY2025 | Aug 25, 2025 | — | — | — | — | $8.00B | — |
| ◌ Q2 FY2025 | May 29, 2025 | — | — | — | — | $8.08B | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | — | — | — | — | $7.81B | — |
| ◌ Q4 FY2024 | Nov 15, 2024 | — | — | — | — | $7.75B | — |
| — Q3 FY2024 | Aug 21, 2024 | — | $0.03 | — | $2.08B | — | — |
| — Q2 FY2024 | May 27, 2024 | — | $0.02 | — | — | — | — |
| — Q1 FY2024 | Mar 20, 2024 | — | $0.02 | — | $4.43B | — | — |
Q2 FY2026
May 27, 2026
EPS Actual
$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$1.60B
Q3 FY2025
Aug 25, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 29, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 15, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 21, 2024
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$2.08B
Q2 FY2024
May 27, 2024
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 20, 2024
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$4.43B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $72.5B | $72.5B | $72.5B | 1 |
| Q2 FY2026 | $70.2B | $70.2B | $70.2B | 1 |
| Q1 FY2026 | $55.4B | $62.0B | $68.5B | 2 |
| Q4 FY2025 | $55.4B | $59.0B | $62.6B | 2 |
| Q3 FY2025 | $61.4B | $62.6B | $64.4B | 3 |
| Q2 FY2025 | $62.8B | $66.3B | $71.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 27, 2026 | — | $3.73 | $3.53 | -5.36% |
| — Q3 FY2024 | Aug 21, 2024 | — | $3.06 | $2.80 | -8.50% |
| — Q2 FY2024 | May 27, 2024 | — | $3.24 | $3.53 | +8.95% |
| — Q1 FY2024 | Mar 20, 2024 | — | $3.22 | $3.22 | +0.00% |
| — Q4 FY2023 | Dec 30, 2023 | — | $3.69 | $3.62 | -1.90% |
| — Q2 FY2023 | Jun 30, 2023 | — | $3.35 | $3.43 | +2.39% |
| — Q1 FY2023 | Mar 31, 2023 | — | $3.78 | $3.86 | +2.12% |
| — Q4 FY2022 | Dec 30, 2022 | — | $4.31 | $4.08 | -5.34% |
Q2 FY2026-5.36%
Report Date
May 27, 2026
EPS Beat/Miss
—
Price Before
$3.73
Price After
$3.53
Q3 FY2024-8.50%
Report Date
Aug 21, 2024
EPS Beat/Miss
—
Price Before
$3.06
Price After
$2.80
Q2 FY2024+8.95%
Report Date
May 27, 2024
EPS Beat/Miss
—
Price Before
$3.24
Price After
$3.53
Q1 FY2024+0.00%
Report Date
Mar 20, 2024
EPS Beat/Miss
—
Price Before
$3.22
Price After
$3.22
Q4 FY2023-1.90%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$3.69
Price After
$3.62
Q2 FY2023+2.39%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$3.35
Price After
$3.43
Q1 FY2023+2.12%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$3.78
Price After
$3.86
Q4 FY2022-5.34%
Report Date
Dec 30, 2022
EPS Beat/Miss
—
Price Before
$4.31
Price After
$4.08
Beat Rate0 / 8 quarters
Largest Move+8.95% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CSPCY ends December
CSPC Pharmaceutical Group Limited (CSPCY) most recently reported earnings on May 27, 2026 for Q2 FY2026, posting EPS of $0.06 (in line with the analyst consensus of —). The next CSPCY earnings date is expected around September 1, 2026.
Each quarter, investors track CSPCY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CSPCY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CSPCY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CSPCY earnings · 4 questionsCSPC Pharmaceutical Group Limited's next earnings report is expected around September 1, 2026. CSPCY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CSPCY historically reports after market close (AMC).
CSPCY earnings datewhen is CSPCY earningsCSPCY next earnings datewhen does CSPCY report earningsCSPCY earnings calendar
▸ Source: FMP · CSPC Pharmaceutical Group Limited SEC filings · US GAAP · CSPC Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026